We listen,
learn, and
deliver.
We are on a mission to deliver medicines that address what matters most.
Tisento is Italian for “I hear you.”
At Tisento, we believe meaningful innovation starts with listening.
We listen to those living with serious diseases to understand the impact of disease on their lives. We also listen to families, clinicians, regulatory agencies, and scientific data. These inputs shape how we conduct our research, design our trials, and evolve our company.
We are on a mission to deliver medicines that address what matters most.
Our focus
Tisento is advancing undisclosed programs addressing significant unmet needs in serious neurological conditions, including rare disorders.
Our team
Our agile team of industry veterans is committed to developing innovative drugs that improve people’s lives. Our dedication to patients, our perseverance, and our passion for advancing Tisento’s mission unite our team.
Meet our team
Allison Burton
Regulatory Affairs Associate
Jennifer Chickering, PhD
Vice President, Program Leadership
Sara (Hagmeier) Ciarametaro, MBA
Senior Director, Finance and Operations
Chad Glasser, PharmD, MPH
Vice President, Clinical Research
Peter Hecht, PhD
Chief Executive Officer
Bill Kissel, PhD
Vice President, Pharmaceutical Operations
Kristin Lurk, MS, PMP
Executive Director, Program Management
Todd Milne, PhD
Chief Operating Officer
Marian Rafferty
Chief of Staff
Wheatley Spence, MS
Head of Regulatory Affairs
Marta Cavero Tomas, PhD
Vice President, IP, Contracts, and Licensing
Matt Webster, MS
Vice President, Clinical Operations
Our board of directors
Paulina Hill
Sanofi Ventures, Board Member
Bryan Roberts
Venrock, Board Member
Peter Hecht, PhD
Tisento, Board Member
Our network
We work closely with an extensive, global network of trusted advisors, thought leaders, advocacy groups, and other collaborators who are partners in our mission. This network complements our focused team, and together we are able to move quickly and tackle big goals on behalf of patients.
In addition, we are proud of our top-tier investor partners who share our vision and power our innovation.
Our investor syndicate also includes other top public and private investors, including our CEO, Peter Hecht.
Contact us
We would love to hear from you! Reach out through the channels below.
General inquiries: hello@tisentotx.com
Partnering/collaboration inquiries: partnering@tisentotx.com
Connect with us on social media:
